IHS Chemical Week

Chemical Week Magazine :: Business & Finance :: Europe/Mideast

Pfizer eyes AstraZeneca for reported $101 billion

6:42 AM MDT | April 25, 2014 | —Natasha Alperowicz

A recent UK press report says that Pfizer has made initial approaches to acquire AstraZeneca for £60 billion ($101 billion) in what would be the world’s largest pharmaceutical acquisition. The two companies have declined to comment on the report, which appeared in The Sunday Times. A deal between Pfizer and AstraZeneca would create one of the top 10 companies worldwide by market value. AstraZeneca has rejected Pfizer’s overtures, according to the report. AstraZeneca is in a transitional phase, with sales and earnings expected to decline for the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa